Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-002918

Director bought 17,781 shares at an average $0.62 ($11,082)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-04 Purchase : show line 1 in the form +6,205 $0.59 $3,661 84,261 D
2019-01-07 Purchase : show line 2 in the form +5,166 $0.63 $3,255 89,427 D
2019-01-08 Purchase : show line 3 in the form +6,410 $0.65 $4,167 95,837 D
Open-market purchases · 17,781 sh · avg $0.62 · $11,082
Loading xslF345X03/doc4.xml…